Waters CorporationWATEarnings & Financial Report
Waters Corporation is an American company headquartered in Milford, Massachusetts that provides analytical instruments and software used for chromatography, mass spectrometry, laboratory informatics, and rheometry by the life sciences, materials, and food industries.
WAT Q3 2025 Key Financial Metrics
売上高
$799.9M
粗利益
N/A
営業利益
$192.1M
純利益
$148.9M
粗利益率
N/A
営業利益率
24.0%
純利益率
18.6%
前年比成長
8.0%
EPS
$2.50
資金フロー
Waters Corporation Q3 2025 Financial Summary
Waters Corporation reported revenue of $799.9M for Q3 2025, with a net profit of $148.9M (18.6% margin). Cost of goods sold was N/A.
Key Financial Metrics
| Total Revenue | $799.9M |
|---|---|
| Net Profit | $148.9M |
| Gross Margin | N/A |
| Operating Margin | 24.0% |
| Report Period | Q3 2025 |
Waters Corporation Annual Revenue by Year
Waters Corporation annual revenue history includes year-by-year totals (for example, 2024 revenue was $3.0B).
| Year | Annual Revenue |
|---|---|
| 2024 | $3.0B |
| 2023 | $2.9B |
| 2022 | $2.8B |
損益計算書
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| 売上高 | $819.5M | $636.8M | $708.5M | $740.3M | $872.7M | $661.7M | $771.3M | $799.9M |
| 前年比成長 | 15.7% | -7.0% | 3.5% | -0.0% | 6.5% | 3.9% | 8.9% | 8.0% |
貸借対照表
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| 総資産 | $4.63B | $4.51B | $4.45B | $4.51B | $4.55B | $4.59B | $4.72B | $4.86B |
| 総負債 | $3.48B | $3.25B | $3.04B | $2.91B | $2.73B | $2.63B | $2.56B | $2.53B |
| 株主資本 | $1.15B | $1.26B | $1.41B | $1.60B | $1.83B | $1.96B | $2.16B | $2.33B |
キャッシュフロー
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| 営業CF | $230.1M | $262.9M | $54.5M | $204.6M | $240.1M | $259.6M | $41.1M | $187.3M |
Other Health Care Companies
ABT
Abbott Laboratories
売上高
$11.4B
純利益
$1.6B
ABBV
AbbVie
売上高
$15.8B
純利益
$186.0M
A
Agilent Technologies
売上高
$1.9B
純利益
$434.0M
ALGN
Align Technology
売上高
$995.7M
純利益
$56.8M
AMGN
Amgen
売上高
$9.9B
純利益
$1.3B
BAX
Baxter International
売上高
$3.0B
純利益
$-1.1B
BDX
Becton Dickinson
売上高
$5.3B
純利益
$382.0M
TECH
Bio-Techne
売上高
$295.9M
純利益
$38.0M
BIIB
Biogen
売上高
$2.3B
純利益
$-48.9M
BSX
Boston Scientific
売上高
$5.3B
純利益
$670.0M